Cyclopharm Outlines Terms of Confidential Institutional Share Placement

Cyclopharm Limited ( (AU:CYC) ) has issued an announcement.

Cyclopharm Limited has released an investor presentation in connection with a confidential, non-underwritten institutional placement of new fully paid ordinary shares, intended for information and discussion purposes only. The company stresses that the material is not a prospectus or formal offer document, does not constitute financial advice or a recommendation to invest, and that any investment decision in its new shares should be made with regard to risks, individual financial circumstances, and independent professional advice.

The most recent analyst rating on (AU:CYC) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Cyclopharm Limited stock, see the AU:CYC Stock Forecast page.

More about Cyclopharm Limited

Cyclopharm Limited is an ASX-listed company operating in the healthcare sector, with a focus on developing and commercialising medical technologies. It issues fully paid ordinary shares and regularly engages with institutional and retail investors through the Australian securities market.

Average Trading Volume: 65,528

Technical Sentiment Signal: Hold

Current Market Cap: A$130M

For a thorough assessment of CYC stock, go to TipRanks’ Stock Analysis page.